Bioactive metallic nanoparticles for synergistic cancer immunotherapy
Cancer immunotherapy has emerged as a promising strategy. However, low response rates and immune-related side effects have plagued immunotherapy. Metallic nanoparticles, utilizing metals as their framework, are gaining prominence in cancer immunotherapy. Metal ions have shown the ability to modulate...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525000991 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850143718066094080 |
|---|---|
| author | Lulu Wang Demin Lin Muqing Li Yu Jiang Yanfang Yang Hongliang Wang Hongqian Chu Jun Ye Yuling Liu |
| author_facet | Lulu Wang Demin Lin Muqing Li Yu Jiang Yanfang Yang Hongliang Wang Hongqian Chu Jun Ye Yuling Liu |
| author_sort | Lulu Wang |
| collection | DOAJ |
| description | Cancer immunotherapy has emerged as a promising strategy. However, low response rates and immune-related side effects have plagued immunotherapy. Metallic nanoparticles, utilizing metals as their framework, are gaining prominence in cancer immunotherapy. Metal ions have shown the ability to modulate immune status by activating the cGAS–STING pathway and inducing immunogenic cell death (ICD), thereby enabling multidimensional activation of immunotherapy. Metallic nanoparticles offer significant advantages in cancer immunotherapy, leading to their increasing use in enhancing therapeutic outcomes. In view of the ever-increasing research on metallic nanoparticles, this review presents the construction, characterization, and enhanced cancer immunotherapeutic effects of different types of metal nanosystems from the perspective of the immunoregulatory mechanisms of metal ions. We delve into the current limitations and future directions of metallic nanoparticles in this rapidly evolving field. To the best of our knowledge, this review offers the most up-to-date and systematic analysis of metallic nanoparticles in immunotherapeutic applications. It is anticipated that this review of metallic nanoparticles will inspire a more refined and intelligent design of metallic nanoparticles for future research, paving the way for advancing their clinical applications. |
| format | Article |
| id | doaj-art-74309d2fd9df414cb8de35edf4fe0ccf |
| institution | OA Journals |
| issn | 2211-3835 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj-art-74309d2fd9df414cb8de35edf4fe0ccf2025-08-20T02:28:37ZengElsevierActa Pharmaceutica Sinica B2211-38352025-04-011541869191110.1016/j.apsb.2025.02.022Bioactive metallic nanoparticles for synergistic cancer immunotherapyLulu Wang0Demin Lin1Muqing Li2Yu Jiang3Yanfang Yang4Hongliang Wang5Hongqian Chu6Jun Ye7Yuling Liu8State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaBeijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaTranslational Medicine Center, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China; Corresponding authors.State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Corresponding authors.State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Corresponding authors.Cancer immunotherapy has emerged as a promising strategy. However, low response rates and immune-related side effects have plagued immunotherapy. Metallic nanoparticles, utilizing metals as their framework, are gaining prominence in cancer immunotherapy. Metal ions have shown the ability to modulate immune status by activating the cGAS–STING pathway and inducing immunogenic cell death (ICD), thereby enabling multidimensional activation of immunotherapy. Metallic nanoparticles offer significant advantages in cancer immunotherapy, leading to their increasing use in enhancing therapeutic outcomes. In view of the ever-increasing research on metallic nanoparticles, this review presents the construction, characterization, and enhanced cancer immunotherapeutic effects of different types of metal nanosystems from the perspective of the immunoregulatory mechanisms of metal ions. We delve into the current limitations and future directions of metallic nanoparticles in this rapidly evolving field. To the best of our knowledge, this review offers the most up-to-date and systematic analysis of metallic nanoparticles in immunotherapeutic applications. It is anticipated that this review of metallic nanoparticles will inspire a more refined and intelligent design of metallic nanoparticles for future research, paving the way for advancing their clinical applications.http://www.sciencedirect.com/science/article/pii/S2211383525000991Cancer immunotherapyMetallic nanoparticlesMetal immunotherapyImmunomodulationTumor microenvironmentCold tumors |
| spellingShingle | Lulu Wang Demin Lin Muqing Li Yu Jiang Yanfang Yang Hongliang Wang Hongqian Chu Jun Ye Yuling Liu Bioactive metallic nanoparticles for synergistic cancer immunotherapy Acta Pharmaceutica Sinica B Cancer immunotherapy Metallic nanoparticles Metal immunotherapy Immunomodulation Tumor microenvironment Cold tumors |
| title | Bioactive metallic nanoparticles for synergistic cancer immunotherapy |
| title_full | Bioactive metallic nanoparticles for synergistic cancer immunotherapy |
| title_fullStr | Bioactive metallic nanoparticles for synergistic cancer immunotherapy |
| title_full_unstemmed | Bioactive metallic nanoparticles for synergistic cancer immunotherapy |
| title_short | Bioactive metallic nanoparticles for synergistic cancer immunotherapy |
| title_sort | bioactive metallic nanoparticles for synergistic cancer immunotherapy |
| topic | Cancer immunotherapy Metallic nanoparticles Metal immunotherapy Immunomodulation Tumor microenvironment Cold tumors |
| url | http://www.sciencedirect.com/science/article/pii/S2211383525000991 |
| work_keys_str_mv | AT luluwang bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy AT deminlin bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy AT muqingli bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy AT yujiang bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy AT yanfangyang bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy AT hongliangwang bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy AT hongqianchu bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy AT junye bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy AT yulingliu bioactivemetallicnanoparticlesforsynergisticcancerimmunotherapy |